In later life, weight loss can be a double‑edged sword. A few pounds off the joints can be both helpful and risky. Shedding a few pounds may ease joint pain, but losing weight without meaning to can be a warning sign. Fast weight loss can also lead to muscle loss, which is key to staying independent.

Experts also point out practical issues: injections need good vision, steady hands, and a regular routine. Stomach and bowel side effects can be tougher for seniors, especially if they’re already losing weight without trying. complicate life for older adults — and how to approach them with a “safety first” mindset.

1) Aging changes the risk–benefit math (even when a drug “works”)

Older adults, especially those who are frail or have several health issues, are often left out of clinical trials. This is important because average trial results may not match the real-life experience of a 75-year-old who takes several medications and needs to manage appetite and hydration.

A 2024 debate paper on GLP-1 drugs in older patients, including those with kidney disease, points out that limited trial data and multiple medications make it harder to judge safety and effectiveness for frailer seniors. Clinicians need to make decisions based on each person, not just on averages. In simple terms, the real question is not whether GLP-1s are good or bad, but whether they help this specific older person with their unique health needs.

There’s another subtle issue: in later life, the goal is often less about chasing an ideal weight and more about protecting function—walking safely, rising from a chair, maintaining balance, staying hydrated, and maintaining enough strength to live independently. So for older adults, the most important question isn’t “How much weight will I lose?” It’s “What will this do to my strength, my nutrition, and my ability to stay steady on my feet?”

2) Common side effects can become serious for older adults.

GLP-1s often cause nausea, vomiting, diarrhea, constipation, and less appetite. Younger people may find these symptoms unpleasant but manageable. For older adults, though, these issues can quickly lead to dehydration, dizziness, and falls, especially if they also take blood pressure medicines or diuretics.

Current FDA labeling for semaglutide products highlights this pathway: stomach and bowel side effects can lead to volume depletion, and acute kidney injury has occurred, including in postmarketing reports. The label advises monitoring kidney function when starting or increasing doses in people who develop severe gastrointestinal reactions, and it notes that dehydration has been part of reported kidney injury cases.

This is how many real-life problems start: a few days of not being able to eat or drink much, then feeling lightheaded, falling, or needing emergency care for dehydration. Older adults may not feel as thirsty and may have less ability to recover. So, it’s important to watch hydration, electrolytes, blood pressure, and kidney function, especially in the first months of treatment and after increasing the dose.

3) Muscle and frailty: losing weight does not always mean better health.

The headline benefits of GLP‑1s often focus on pounds lost. But the body doesn’t lose only fat. Lean mass (including muscle) can drop, too. This matters in older adults because age‑related muscle loss (sarcopenia) is already common — and it’s tightly linked to frailty, falls, and loss of independence.

A 2025 mini-review on older adults warns that starting and stopping GLP-1s repeatedly can change body composition, sometimes leading to ‘sarcopenic obesity’ — having too much fat and too little muscle. The authors are not saying to avoid GLP-1s, but to remember that weight loss does not always mean better health for older people.

More pointedly, a 24‑month retrospective cohort study in older adults with type 2 diabetes reported that semaglutide use was associated with muscle loss and functional decline, particularly at higher doses and in patients who already had sarcopenia. The authors emphasize individualized risk–benefit assessment and the need for monitoring and intervention.

If you’re reading this as an older adult, it may help to translate the research into plain questions to bring to your next appointment: “If I lose weight, how will we protect my muscles?” “How will we check whether I’m getting weaker?” “What would make us stop or change course?” An older adult who becomes “smaller but weaker” has not gained health — only risk.

4) Other complications: gallbladder, pancreas, vision, and low blood sugar

Gallbladder and bile duct problems can be an unexpected issue. Losing weight already increases the risk of gallstones, and GLP-1s seem to increase it even further. A large review found that using GLP-1 drugs increases the chance of gallbladder or bile duct disease, especially at higher doses, for longer periods, or when used for weight loss.

For older adults, this might present as sudden pain in the upper right side of the belly, nausea, fever, or pain spreading to the back or shoulder. These symptoms should be checked by a physician right away.

GLP-1 drug labels also warn about the risk of sudden pancreatitis and say to get medical help for severe, ongoing belly pain. The overall risk is low, but older adults may have additional risk factors, such as gallstones or high triglycerides. Severe belly pain in later life should always be checked quickly.

Then there’s the risk of blood sugar dropping too low. GLP‑1s don’t usually cause hypoglycemia by themselves, but the risk rises when combined with insulin or sulfonylureas. Semaglutide labeling warns that concomitant use with an insulin secretagogue or insulin may increase the risk of hypoglycemia and may require dose reductions of those agents.

In older adults, hypoglycemia can be particularly dangerous: it can cause falls, confusion, fainting, and cardiac stress. It’s also easier to miss, because symptoms may look like “just being tired” or “a little off today,” especially in someone who already has memory or balance problems.

Eyes and vision deserve special attention. Semaglutide labeling includes a warning about diabetic retinopathy complications and recommends monitoring patients with a history of retinopathy. Beyond labeling, post‑marketing safety monitoring continues to explore visual signals.

A 2025 analysis of FDA adverse event reporting data found a potentially elevated risk of vision‑impairment reports with semaglutide use compared with some other diabetes and weight‑loss medications, and it called for vigilant surveillance and further research. That doesn’t prove the drug causes vision loss in an individual patient, but it is enough to justify a cautious posture: new blurring, blind spots, or sudden changes deserve a same‑week medical call, not a “let’s see if it passes.”

5) Surgery and sedation: delayed stomach emptying can cause problems

GLP‑1 medications slow stomach emptying — one reason people feel full sooner. But that same effect can complicate anesthesia and deep sedation if food remains in the stomach despite standard fasting. A 2024 review describes the connection between GLP‑1 medications, delayed gastric emptying (including gastroparesis), and increased risk of aspiration during anesthesia, as well as possible effects on the absorption of other medications.

This issue has become important enough that several medical groups have created guidelines for surgery. The 2024 guidance says many people can continue taking GLP-1s, but doctors should look for higher-risk situations, such as people with stomach problems or other risks of food entering the lungs, and adjust plans as needed.

This is important for older adults because they are more likely to undergo procedures requiring sedation, such as colonoscopies, joint injections, cardiac procedures, dental work, or surgeries. The easiest and most often missed safety step is to tell every physician involved — surgeon, anesthesiologist, endoscopist, dentist — that you are taking a GLP-1 medication and when you last took it. Do not assume it will be clear in your medical chart.

6) A senior‑friendly “yes, with a plan” approach

If you’re an older adult considering a GLP‑1 (or already taking one), a safer approach often looks like “yes, with monitoring.” That means starting with function, not just the scale: tracking energy, steadiness, and strength in everyday life, not only pounds.

It also means treating hydration as a real medical concern. Ongoing nausea, vomiting, or diarrhea is not just part of getting used to the medicine. These symptoms can affect blood pressure and kidney function, especially when changing doses.

Because muscle matters so much in later life, protecting it should be part of the prescription. That can include discussing protein intake, adding a realistic strength plan (even chair‑based work or physical‑therapy guided resistance), and reassessing the medication if weight loss is accompanied by weakness, poor balance, or reduced stamina.

Older adults should also have their medications reviewed with a focus on preventing low blood sugar. If insulin or a sulfonylurea is being used, doses may need to be adjusted as appetite decreases and blood sugar improves.

Finally, it is important to take symptoms seriously. New stomach pain, ongoing vomiting, or sudden vision changes should be checked by a doctor right away. Before any procedure with anesthesia or deep sedation, make sure to tell the medical team about your GLP-1 use — do not assume they already know.

The GLP-1 medications can help some older adults, but there is less room for mistakes. Side effects can quickly lead to dehydration, frailty, falls, or problems during procedures. The safest approach is not just ‘yes’ or ‘no,’ but ‘yes, with a plan’ — one that protects hydration, nutrition, muscle, vision, and safety during medical care.

The post GLP‑1 Medications in Later Life: Why the “Miracle Shot” Needs a Senior‑Specific Safety Lens appeared first on Medika Life.

SNAP is not an abstract line item. It is a lifeline for nearly 42 million Americans, one in eight citizens. In fiscal year 2024, the program distributed almost $100 billion in benefits, with the average recipient receiving approximately $187 per month. For families living paycheck to paycheck, this is the difference between nourishment and hunger, health and hardship.

War on Poverty

SNAP’s history reveals both bipartisan vision and enduring necessity. The program originated during the early 1960s as a pilot effort to stabilize farm prices and reduce hunger. In 1964, President Lyndon Johnson signed legislation making the Food Stamp Program permanent as part of his War on Poverty. His message to Congress was clear: a nation strong enough to feed the world must also be able to feed its own people.

Through the decades, the program evolved from paper coupons to electronic benefits, and in 2008, it was rebranded as the Supplemental Nutrition Assistance Program to emphasize nutrition and dignity rather than charity. That renaming symbolized an essential truth – food security is fundamental to health, not a handout. SNAP has survived political shifts and economic crises because it reflects a moral consensus: no one in America should go hungry.

Who Relies on SNAP

The faces behind SNAP are as diverse as the nation itself. Nearly 40 percent of participants are children, and another 20 percent are seniors. Millions of adults are living with disabilities, many of whom also qualify for Medicare regardless of age. For individuals managing chronic conditions, experiencing mobility limitations, or living on a fixed income, SNAP assistance serves as a proven vital lifeline for maintaining preventive health.

Often sympathetic to the Administration, a Fox News story shared the fear many are now experiencing. A cancer survivor who depends on disability benefits described how the possible halt in SNAP payments left her anxious and uncertain: “It’s scary. I really need the extra for food, because by the time I pay all the bills, there’s really nothing left.” Her story mirrors that of millions who balance medication co-pays against grocery costs, forced into trade-offs that jeopardize both health and dignity. Let’s not forget paying for housing and transportation.

Working families are also part of this equation. Many SNAP households have at least one employed adult. The wages are not enough to cover rent, childcare, transportation to work and medical bills, so food becomes the only variable expense they can afford to cut. SNAP ensures that food insecurity doesn’t become the hidden cost of low-wage work.

What SNAP Provides

SNAP benefits are issued through an EBT card and can be used to purchase fruits, vegetables, meats, fish, poultry, dairy products, bread, cereals, and even seeds and plants to grow food. They cannot be used for alcohol, tobacco, hot prepared meals or household items. The program supplements, rather than replaces, household food budgets, providing predictability that allows families to direct scarce income toward other essentials.

For the health system, SNAP is prevention in action. Food insecurity fuels chronic disease and poor health outcomes. According to the Centers for Disease Control and Prevention, adults experiencing food insecurity are 2 to 3 times more likely to develop diabetes and more than twice as likely to suffer from depression. Children in food-insecure households face 19% higher odds of hospitalization before age three and significantly higher risks of anemia, asthma, and behavioral problems.

A study published in JAMA Internal Medicine found that SNAP participation was associated with a 14% reduction in emergency department visits and lower overall healthcare expenditures. When families can afford healthy food, chronic illness becomes more manageable, adherence to medications improves, and children achieve better developmental outcomes. Conversely, disruptions in SNAP benefits correlate with spikes in hospitalizations for malnutrition, hypoglycemia and mental-health crises.

SNAP functions as one of this nation’s most effective public-health interventions, less visible than vaccines or prescription drugs, and essential to community well-being.

The Big Apple, Empire State and the Nation

The human impact of this shutdown can be seen most vividly on the streets of New York City, where nearly 1.73 million residents, about one in five New Yorkers, depend on SNAP to make it through the month. Grocery stores in the Bronx, Queens, and across the five boroughs see the direct connection between Federal stability and neighborhood well-being. When SNAP dollars are delayed, the effects ripple far beyond individual households: local grocers lose revenue, food pantries face longer lines, and families already budgeting every dollar must make painful trade-offs between groceries, rent and medicine. Child care for working parents is already an out-of-reach luxury.

At the state level, the scale becomes even more striking. As of January 2025, nearly three million New Yorkers –from Buffalo to Brooklyn – received a combined $655.9 million in SNAP benefits that month. These benefits circulate quickly through communities, sustaining small businesses and providing a stabilizing force in counties where economic opportunity fluctuates with the seasons. The State Comptroller’s office estimates that more than $7 billion flowed to New York households in the last fiscal year through SNAP. This Federal investment fuels local economies while preventing hunger from escalating into a public-health emergency.

Nationally, these numbers paint a powerful and painful picture of need and vulnerability. Across the United States, roughly 42 million people, one in eight Americans, rely on SNAP each month. The Federal government must provide approximately $9 billion monthly to sustain those benefits; however, contingency funds currently fall billions of dollars short of that requirement. That gap is not theoretical. Food banks and community kitchens from California to Kentucky are already bracing for the overflow, warning that their shelves and volunteers cannot absorb the loss of a Federal program that moves food on a national scale.

From a New York City food pantry to a rural supermarket in upstate counties, the story reverberates: SNAP keeps families fed, children nourished and local businesses viable. When the Federal system stumbles, the consequences cascade, turning this government shutdown into a community crisis.

A few days ago, a Federal judge ordered the government to use all available contingency funds to sustain SNAP. Still, those dollars fall short of the roughly $9 billion needed for November benefits. The result is confusion, fear and logistical strain. Governors and mayors across the country are scrambling to respond to the crisis. In New York City, Mayor Eric Adams announced $15 million in emergency funding to bolster food pantries and community kitchens. State agencies are urging residents to call 311 in the city and 211 statewide to find food resources.

Still, no local initiative can replace the Federal infrastructure that delivers food assistance on a national scale. Charity can fill temporary gaps; however, it cannot replace the efficiency, reach and consistency of a program built to prevent hunger in the first place.

Health and Economic Stakes

SNAP is among the most cost-effective anti-poverty and public-health tools the nation has ever introduced. Every dollar in benefits generates approximately $1.50 to $1.80 in economic activity, circulating through local farmers, grocers and supply chains. When benefits are delayed or reduced, families face impossible choices between food and heat, or groceries and prescriptions. Hospitals see higher emergency visits; schools see lower attendance and test scores; local economies contract.

A CNN analysis broadcast this week underscores the link between nutrition and resilience. The report notes that food insecurity not only increases health costs but also reduces life expectancy. People living in food-insecure households have a 32% higher risk of premature mortality from preventable disease. Supporting food banks helps in the short term, but it cannot replace a Federal program designed to prevent hunger on a larger scale.

Without SNAP, the nation’s social safety net frays, leaving millions exposed to physical and psychological harm and the country’s public-health foundation weakened.

The Social Impact

Food assistance is not a partisan favorite; it is a measure of a vibrant society caring for its most vulnerable. SNAP’s durability across administrations reflects a shared American understanding: no child should be hungry because adults can’t agree. The current shutdown tests the consensus and the moral fiber of the nation’s leadership.

From the individual with a disability counting on SNAP to stay fed, to the child trying to learn on an empty stomach, to the local grocer whose shelves depend on steady EBT purchases, the stakes are not political. They are human. As winter approaches, this must not become the season when America’s nutrition safety net blinks and citizens are left in the cold.

The post SNAP at Risk: What a Shutdown Means for Health and America’s Social Contract appeared first on Medika Life.

I was standing in my kitchen at 1:07 a.m., the only illumination a cold rectangle from the refrigerator.

It felt like a reversed Caravaggio scene. Darkness everywhere, a harsh pool of light on a plate of leftovers.

I was not hungry.

The light wired me awake. It felt like an invitation to eat.

I am a radiation oncologist.

I discuss circadian clocks with patients more often than most in my specialty because I’ve seen, over decades, how sleep, light, food timing, stress, and movement influence recovery, inflammation, and weight.

When you sit in a treatment room for a long enough time, you start to notice patterns.

People who live in bright evenings and dim mornings often struggle with appetite, cravings, and maintaining a healthy body composition.

They are swimming upstream against their biology.

This is the essay I wish someone had handed me ten years ago.

Light is not neutral.

It is a metabolic signal.

And the way we dose it each day can quietly nudge our insulin, our melatonin, our leptin and ghrelin, our brown fat, and even the clocks inside our liver and pancreas.

Let me show you how to use that to your advantage.

The Night I Realized Light Exposure Could Make You Fat.

In the clinic, I began asking a new question: not just how many hours you sleep, but how much light hits your eyes after sunset.

Most patients stared. Then came the stories: three glowing screens, bright LEDs in the bedroom, a dog walk under sodium street lamps.

Late light. Fragmented sleep.

Late eating. Creeping weight.

Our fat cells tell time. So do our mitochondria. So does your gut microbiome.

Light at the wrong time scrambles those clocks. Scrambled clocks change how you store energy.

Your Fat Has a Clock: Circadian Rhythm, Metabolism, and Weight Gain.

Every cell in your body keeps time.

Morning light anchors the master clock in your brain, which in turn syncs the clocks in your organs and fat cells.

Weak morning light and strong evening light throw those clocks out of phase.

The result is a subtle metabolic jet lag that never ends.

Quiet jet lag doesn’t show up on your calendar. It shows up on your scale.

Melatonin, insulin, and the late-night snack

Melatonin is not just a sleep hormone.

It cross-talks with insulin.

When melatonin levels are high, your ability to handle glucose decreases.

That is adaptive if you are asleep.

It is not adaptive if you are scrolling with a bowl of cereal near midnight.

Bright light at night suppresses melatonin, delays sleep, and shifts appetite later.

You wake underslept, with more ghrelin, less leptin, and a stronger drive to eat ultraprocessed food.

Rinse. Repeat.

Want to reset your metabolism?
→ Get my Micro-Habits bundle for daily light protocols, circadian checklists, and the exact scripts I give patients.

Morning light is metabolic medicine.

Ten minutes of unfiltered outdoor light soon after waking can move your circadian clock earlier, deepen your sleep that night, and improve next-day insulin sensitivity.

Morning light is rich in wavelengths your brain needs to set the day. Indoors, even bright-looking rooms are often one or two orders of magnitude dimmer than outside.

Your brain can tell the difference. So can your pancreas.

If you do one thing after reading this, step outside within 30 minutes of waking.

If it is cloudy, go anyway. If it is winter, aim longer. Treat it as you would a prescription.

Darkness is a habit

We talk about sleep hygiene.

We rarely talk about darkness hygiene.

Your retina is exquisitely sensitive to blue light, but even dim bulbs can disrupt your sleep cycle.

Swap bedside LEDs for warm, low-lux bulbs.

Set your phone to grayscale and enable a screen sunset. Cover the power lights with black tape.

Close the fridge quickly. Dim your home two hours before bed until it resembles a Rembrandt painting.

Your metabolism prefers Rembrandt over Times Square.

What I tell patients in the clinic

1. See the morning light early and consistently.
2. Eat most of your calories in the daylight zone.
3. Dim the house two hours before you want to sleep.
4. Stop eating at least two to three hours before going to bed.
5. Keep the bedroom dark, cool, and free of screens.
6. Anchor wake time seven days a week.
7. Move your body in the day, not at midnight.
8. Treat shift work like altitude. You need extra recovery, extra discipline, and a plan.

Micro-habits that fix your light diet

• Lux-before-latte rule: no coffee until you have been outside.
• Two-switch protocol: one button that turns off all bright overheads at 8 p.m., one that turns on warm lamps. Make darkness effortless.
• Yellow-card your phone: night shift mode, grayscale, and a screen curfew you respect.
• Front-load protein: bigger breakfast and lunch, smaller dinner. Your insulin sensitivity is higher earlier.
• Walk after dinner: even ten minutes blunts the glucose spike and helps your clock wind down.
• Bedroom audit: cover LEDs, use blackout curtains, move chargers to the hallway.
• Weekend consistency: Social jet lag is a form of metabolic jet lag. Keep your wake time within 60 minutes of weekdays.

The lab evidence in plain English

Animal models demonstrate that mistimed light exposure leads to weight gain, even without consuming extra calories.

Human studies have linked nighttime light exposure to a higher BMI, poorer sleep, and worse glucose control.

Shift workers have higher risks of obesity, diabetes, and some cancers.

These conditions are not destiny. They are signals you can change.

If you still want numbers

Chronobiology papers repeatedly show that eating the same calories at night causes a higher postprandial glucose and insulin response than eating them in the morning.

Timed light therapy can correct delayed sleep phase and improve metabolic markers.

Dim light at night correlates with higher rates of depression and weight gain.

Again, correlation is not causation, but the mechanisms are biologically sound.

A one-week protocol to test on yourself

Day 1 to 2

• Wake at the same time both days.
• Get 15 minutes of outdoor light within 30 minutes of waking.
• Track meals. Eat 80 percent of calories by 4 p.m.
• Dim the house lights at 8 p.m. Aim for minimal screen time.
• Sleep in full darkness.

Day 3 to 7

• Extend morning light to 20 minutes.
• Add a 10-minute post-dinner walk.
• Keep dinner smallest and earliest.
• Keep wake time strict.
• Note morning hunger and energy. By day 4, many people report fewer nighttime cravings.

How this plays out in the real world

A patient with breast cancer told me she could not lose weight despite “doing everything right.”

She tracked calories, lifted weights, and avoided ultraprocessed foods. She also answered emails at midnight under bright LED downlights and ate a second dinner at 10:30 p.m.

We moved her dinner to 6 p.m., instituted a house-wide dim at 8 p.m., added morning light exposure, and asked her to maintain a stable wake time, even on weekends.

Six weeks later, she had lost six pounds without changing her total calorie intake.

Her sleep improved. Her cravings diminished.

The scale finally listened.

The broader stakes of light exposure and weight gain

We are the first species to flood the night with light and the day with dimness.

We built a 24-hour culture and then wondered why our biology pushed back.

Weight gain is not a character flaw.

It is often a circadian mismatch.

Fix the light. Observe the effects on hunger, sleep depth, glycemic control, and weight.

Final Thoughts

Light is a drug.

Dose it wisely.

Morning heals.

Evening disrupts.

Darkness is a habit, not a switch.

If your weight has been creeping up, remember this: your first diet is not on your plate.

It is in your eyes.

→ Want my full circadian reset, daily checklists, and Micro-Habits plan? Get the Micro-Habits bundle today.

→ Follow me here on Medium for more science-backed, story-driven guides to living longer and better.

Author bio: I am a radiation oncologist who writes daily about longevity, cancer prevention, and the small habits that change health trajectories.

The post The Strange Link Between Light Exposure and Weight Gain appeared first on Medika Life.

In Malaysia, I ate like a poet unchained.

Noodles in the morning.

Spiced broth at noon.

Chicken glazed with soy and garlic by nightfall.

I sat on plastic stools under humming fans.

I picked up late-night snacks from carts where the only menu was memory and steam.

I ate more than usual.

I felt full every day.

But when I returned home, the scale surprised me.

Two pounds lighter.

My steps had not changed.

My sleep was the same.

I tracked nothing.

I restricted nothing.

Yet somehow, my body felt clearer, lighter, and calmer.

That was the moment I understood.

The issue was not how much I had been eating.

It was what I had been eating.

Here’s the bar of my Penang hotel:

The Research Now Makes It Obvious

A major review published in Nature Reviews Endocrinology confirmed what I had already suspected.

Ultra-processed foods, often called UPFs, are not just harmless conveniences.

They actively promote overeating, disrupt metabolism, and increase the risk of obesity and chronic disease.

Researchers reviewed decades of data.

Their conclusions were clear:

• UPFs override your sense of fullness
• They damage the gut microbiome
• They interfere with hormones like insulin and leptin
• They promote chronic inflammation
• They increase the risk of early death

These are not neutral calories.

They are chemical provocations.

→ Want to know which “health facts” are wrong?

Download my free guide: Debunked: 7 Health “Facts” That Are Quietly Hurting You

.

From Preservation to Manipulation

A century ago, food processing helped prevent disease.

Preservatives and fortification solved real problems like spoilage and vitamin deficiencies.

But today’s ultra-processed foods are something else entirely.

They are stripped of fiber and water.

They are saturated with sugar and salt.

They are softened or crisped for speed.

They require little chewing and deliver maximum pleasure in minimal time.

These are not foods made to nourish.

They are products made to disappear.

What I Noticed in Malaysia

In Penang and Singapore, I kept waiting for the usual signs.

Cravings.

Energy crashes.

That pull toward sugar at night.

None of them came.

Instead, I ate whole and real foods.

Greens stir-fried in oil.

Fish with bones intact.

Rice, fruit, spice, and broth.

Even the desserts had substance.

Even the snacks had structure.

And every bite required chewing.

What Ultra-Processed Foods Really Do

The review and related studies show that UPFs:

• Speed up how fast we eat
• Bypass satiety signals
• Starve the beneficial bacteria in the gut
• Trigger a hormonal imbalance
• Promote low-grade inflammation
• Crowd out nutrient-rich foods

One U.S. study linked high UPF intake to more than 120,000 preventable deaths each year.

Another found strong associations with cardiovascular disease, type 2 diabetes, and cognitive decline.

This finding is not just about gaining weight.

It is about how these foods affect nearly every system in the body.

Labels Lie. Chemistry Tells the Truth.

UPFs often pretend to be healthy.

They say low-fat, gluten-free, plant-based, or high-protein.

But flip the package and the label tells a different story.

You’ll find artificial flavors, gums, starches, stabilizers, and sweeteners you can’t pronounce.

You’ll find them in:

• Protein bars
• Ready-to-drink shakes
• Flavored yogurts
• Cereal with cartoon characters
• Shelf-stable snacks that never spoil

These foods don’t just deliver calories.

They confuse your hunger.

They dull your instincts.

They keep you coming back.

What I Now Tell My Patients

Instead of strict food rules, I offer simple replacements.

• Eat foods with fewer than five ingredients
• Choose oats over cereal
• Choose fruit over a bar
• Choose nuts over crackers
• Cook when you can, even if it’s just olive oil, garlic, and greens

Real food asks you to chew.

It slows you down.

It satisfies you in a way engineered foods cannot.

You don’t need to be perfect.

You only need to shift direction.

Letting Go Is Hard for a Reason

Manufacturers design ultra-processed foods to be addictive.

They melt in your mouth.

They hit the same reward centers as nicotine.

They are easy to chew and hard to resist.

They make you eat faster and feel less full.

This is not a failure of willpower.

This is a feature of the product.

Start small:

• Replace soda with sparkling water and lime
• Prep one simple meal a week
• Add a vegetable to each dinner
• Keep one snack unprocessed

The smallest shift creates momentum.

And momentum is what makes change last.

Final Thoughts: Hunger Is a Signal

In Malaysia, I stopped thinking about food.

I didn’t count macros.

I didn’t obsess over protein.

I ate when I was hungry and stopped when I was full.

Because the food I was eating allowed me to stop.

When I walked through the airport food court back home, everything looked different.

It wasn’t the smell that hit me.

It was the stillness.

The silence.

The lifelessness of boxes filled with shelf-stable meals and snack bars designed by chemists, not chefs.

And I realized something.

Hunger is not always a request for food.

Sometimes, it is a call for something real.

→ Want my full circadian reset, daily checklists, and Micro-Habits plan? Get the Micro-Habits bundle today.

→ Bonus: Like This Format?

Want more science-backed habits like these? → Follow me for new guides every Tuesday, or explore this reader favorite on building daily resilience.

Author bio: I am a radiation oncologist who writes daily about longevity, cancer prevention, and the small habits that change health trajectories. I’m a physician and writer who helps people understand how everyday habits shape long-term health. I believe food should fuel, not fool, the body.

The post The Silent Additive: What Singapore Street Food Taught Me About Ultra-Processed America appeared first on Medika Life.

Higher scores for diet quality and greater consumption of shortfall nutrients, especially nutrients of public health concern, are associated with dietary patterns that are rich in canned and dry beans. Improved weight-related outcomes are also linked to bean dietary patterns. In essence, dietary recommendations for the United States should consider the nutritional and health advantages of encouraging more people to eat canned and dry beans.

But plant-based diets have some benefits that may surprise many. Reduced mortality from prostate cancer and improved ecological sustainability are only two of the several advantages of plant-based diets.

According to a recent study conducted by academics, beans and peas are the most cost-effective and environmentally friendly alternatives to meat and milk. Given the current emphasis on environmental and climate change, we must consider alternatives to our current meat-based diet and assess their value.

The study published in the PRNAS found that soybeans, peas, and beans, as well as other legumes, performed better than processed foods like veggie burgers and plant milks.

Even after considering possible savings and investments, lab-grown meat was the most ineffective substitute due to its expensive price tag and the absence of health advantages.

What’s This About “Pulses?”

Pulses have become less common in people’s everyday diets and the prevalence of chronic diseases has increased during the last century, both of which have altered people’s eating patterns. Whole grain and legume consumption is associated with improved cardiovascular, metabolic, and cognitive health as well as longer life expectancy, according to both a priori and a posteriori dietary patterns. Contrarily, cardiovascular disease and premature death have been linked to diets heavy in sugar, processed foods, and red meat.

Some examples of pulses are peas, beans, and lentils. As an illustration, while pea pods are legumes, the peas within them are the pulse. While most of us eat legumes for their seeds or pulses, the whole plant is used in agriculture for cover crops, cattle feed, and fertilizers. Pulses include beans of many varieties, including kidney, black, pinto, navy, chickpeas, and many more. (This information was sourced from: https://nutritionsource.hsph.harvard.edu/legumes-pulses/). But pulses aren’t the only thing to consider. For example, beans are “resistant starches” and that is the importance they bring to our diet.

Everyday foods often contain starch, a type of carbohydrate. After cellulose, it is the chemical component found in plants in the highest abundance. In its chemical form, starch consists of two molecules of monosaccharide. Starch falls into one of three types according to its physical and physiological characteristics: quickly digestible, slowly digested, or resistant starch. It was also discovered that resistant starch remained undigested. Research has shown that the gut microbial communities make use of these undigested carbohydrates. Here is where all the magic starts.

Resistant starch does not produce an increase in blood sugar levels since it is not broken down in the small intestine. Beneficial bacteria proliferate while harmful bacteria deplete as a result of fermentation in the large intestine, leading to an improvement in gut health. Glycemic management (especially important for diabetic patients) can be enhanced by promoting healthy gut bacteria. A reduction in cholesterol levels and the danger of colon cancer are among the other advantages of resistant starch. It also helps with constipation and both treats and prevents it. Because of its long fermentation process, resistant starch produces less gas than other fiber types.

Our best sources of resistant starch foods include:

• Plantains and green bananas (as a banana ripens, the starch changes to regular starch)
• Beans, peas, and lentils (white beans and lentils are the highest in resistant starch)
• Whole grains, including oats and barley
• Cooked and cooled rice. Why “cooled” rice? Because it increases the resistant starch content.

So, beans aren’t the only food with resistant starch qualities, but they are the easiest to obtain and least expensive when prepared in dried form. Canned beans may seem fine for quick meals, and that’s true, but they also may contain high levels of salt, which is unsuitable for anyone’s diet.

Concerned about your health and that of the plant? Reconsider a plant-based diet and beans as a staple in your meals.

The post Beans Are Now the Super Food That We All Need, So Get Ready for a New Diet appeared first on Medika Life.

It’s a brilliant question — practical, personal, and rooted in lived experience.

We’ve all been there: eating blueberries, sipping matcha, nibbling dark chocolate, hoping it’ll offset the chaos of our lives.

We’re told that foods like blueberries are miracle cures — that if we just eat clean enough, we can outrun stress.

But here’s what I’ve seen in practice:

You can’t eat your way out of chaos.

→ Why Everyone’s Brain Feels Broken Right Now — And What I Tell My Patients

Still, food matters. Deeply.

Let’s unpack what antioxidant-rich foods can do for a burned-out brain — and where their power ends.

(P.S. That “Let food be thy medicine” quote? Not really Hippocrates.)

What Are High-ORAC Foods, Anyway?

ORAC, short for Oxygen Radical Absorbance Capacity measures how well a food can neutralize free radicals (unstable molecules that damage cells, accelerate aging, and promote inflammation).

Some of the highest-ORAC foods include:

These are some of the most evidence-based foods that fight burnout by countering oxidative stress and inflammation.

Consuming these foods regularly can make your body more efficient at extinguishing the “metabolic fires” triggered by stress, poor sleep, and inflammation.

So yes, these foods help.

But they’re not enough.

Stress, Sleep, and the Limits of Diet

Take a real-world example:

A 49-year-old entrepreneur came to me burned out.

She exercised.

Ate mostly plants. Drank matcha. Took magnesium.

Still exhausted. Irritable. Foggy.

Why?

She was sleeping five hours a night, answering emails at midnight, skipping meals, and never pausing.

Her nervous system was locked in a state of fight-or-flight.

And even the most antioxidant-rich foods won’t restore the parasympathetic state we need to digest, repair, and think clearly.

Nutrition supports healing, but it doesn’t initiate it when the system is overloaded.

Curious how patients actually recover from burnout? My ebook, What Dying Patients Taught Me About Living, shares what I’ve seen firsthand.
👉 [Get your copy here]

What Antioxidants Can Do

So what can antioxidants do?

A nutrient-dense, antioxidant-rich diet can help:

• Lower CRP (a marker of inflammation)
• Improve cognition under stress.
• Stabilize mood via the gut-brain axis.
• Protect mitochondria from oxidative stress.
• Support neurogenesis (yes, new brain cell growth)

These are some of the most powerful antioxidant benefits for the brain — and they’re magnified when paired with rest and rhythm.

One 2023 study found that a Mediterranean-style, antioxidant-rich diet was linked to a lower risk of depression.

Related: 10 Tiny Habits That Quiet Your Mind — Without Meditating

Another study showed that people who consumed more polyphenol-rich foods had better memory scores, regardless of their sleep quality.

The takeaway? Antioxidants can buffer the damage. But they can’t reset the machine.

What They Can’t Do

Let me be direct:

No number of blueberries can fix:

• Poor sleep hygiene
• Work addiction
• Emotional suppression
• Constant digital overload

Clean eating can quietly backfire — especially when it becomes a way to control life instead of nourish it.

Food is a foundation, not a fix.

What Actually Works (In Real Life)

Here’s what I tell patients when they’re doing all the “right” things — but still feel off:

1. Anchor meals to rhythm, not mood

Eat at consistent times daily. This stabilizes your gut clock and supports digestion.

2. Start the day with color

Aim for 3+ natural colors before noon: blueberries, spinach, turmeric, red pepper.

3. Pair food with ritual

Eat away from screens. Use real dishes. Go outside if you can. This activates your parasympathetic system.

4. Don’t supplement stress away

Magnesium, ashwagandha, resveratrol — all useful. But only after the basics are covered: sleep, movement, light, and breath.

5. Get morning light every day

Even 10 minutes of sunlight in the first two hours after waking can reset your circadian rhythm, improve sleep, and reduce stress reactivity.

Rhythm Over Rescue

Here’s the core truth:

Health isn’t about rescue. It’s about rhythm.

We chase the perfect food, supplement, or hack to undo imbalance.

But the body doesn’t crave intensity.

It craves consistency.

Yes, antioxidant-rich foods help.

But when food is paired with consistent rest, movement, morning light, connection, and meaning?

That’s when transformation happens.

A Series for the Questions That Matter

Reader questions shape how I practice medicine — and how I write.

If this one resonates, know this:

You’re not alone. Many of you are doing the right things, just in the wrong context.

You can eat perfectly and still feel off.

When food becomes a companion to healing, not a crutch, that’s when the real magic begins.

The food is just the beginning.

Healing comes when your life makes space for rest.

Download my recent ebook:
My latest ebook: What Dying Patients Taught Me About Living
👉 Grab your copy here.

Read next:
→ 25 Tiny Habits That Strengthen Mental Health
→ The Silent Fire: How Chronic Inflammation Fuels Aging — and 4 Ways to Cool It Down
→ 10 Tiny Habits That Recharge You, Without Quitting Your Job

Author bio: Michael Hunter, MD, is a cancer physician, over-60 competitive bodybuilder, and bestselling wellness writer. His latest ebook is available here.

Illustration generated using ChatGPT’s image tools.

The post Can Blueberries Save You From Burnout? appeared first on Medika Life.

A new independent analysis conducted by actuarial firm Milliman reveals that FlyteHealth’s AI-enabled Comprehensive Obesity Care program, piloted in partnership with the State of Connecticut, yielded both high medication adherence and meaningful short-term cost avoidance within its first year.

A Real-World Test: Public Sector, Private Innovation

Faced with surging costs tied to GLP-1 coverage since 2020, Connecticut’s self-insured employee health plan took a bold step in 2023 by launching a pilot with FlyteHealth to better manage obesity treatment for eligible employees and retirees. The results: a projected $1.2 million in pharmaceutical cost avoidance and an 86% adherence rate among new GLP-1 users—figures that far surpass national benchmarks.

In typical commercial settings, just 32% of patients remain on GLP-1 therapy after one year. Worse, only 27% follow their prescribed dosing schedules. These statistics often lead payers to pull back on coverage. But FlyteHealth’s personalized, tech-enabled approach may offer a path forward that makes medical and fiscal sense.

Clinical Expertise Meets AI-Driven Personalization

FlyteHealth’s model blends decades of clinical experience with data intelligence. The care program is rooted in the methodology of obesity medicine expert Dr. Louis Aronne and powered by a patent-pending AI engine that tailors care plans based on individual biometric and behavioral data.

Patients receive virtual care from a multidisciplinary team—physicians, nurse practitioners, and dietitians—alongside medication management, lifestyle coaching, and digital support via wearables and connected devices.

The program’s precision prescribing approach uses BMI-based triage to match patients with the most appropriate treatments, reserving higher-cost medications for those with more severe obesity.

State Leaders Applaud Value-Driven Innovation

“This partnership with FlyteHealth is a clear example of how forward thinking, evidence-based innovation can improve people’s lives while also protecting taxpayer dollars,” said Connecticut State Comptroller Sean Scanlon. “The results show we can deliver high-quality care that’s both clinically effective and fiscally responsible.”

Cheryl Pegus, MD, MPH, FlyteHealth’s executive board chair, echoed that sentiment: “Employers and payers are rightly concerned about costs and access. FlyteHealth is committed to supporting those goals with proven, cost-effective solutions.”

Beyond Cost: Patient Outcomes and Long-Term Potential

While the Milliman study focused solely on pharmaceutical spending, FlyteHealth reports additional health improvements among participants, including:

• A 7.2% reduction in elevated HbA1c
• A 9.4% drop in blood glucose levels
• 13%–16% average weight loss over 12 months

The clinical team also addressed comorbidities such as sleep apnea, steatohepatitis, and cardiovascular disease—highlighting the comprehensive nature of the program.

FlyteHealth CEO Sloan Saunders emphasized that these results demonstrate more than momentary success: “Milliman’s independent analysis validates our model’s ability to achieve patient adherence, optimize resource use, and create meaningful savings. But this is just the start—we’re focused on long-term health and economic impacts.”

Looking Ahead

FlyteHealth plans to evaluate broader medical cost offsets and total cost-of-care reductions in future studies. As demand grows for solutions that bridge innovation with fiscal responsibility, the Connecticut pilot could serve as a national model for scalable, AI-informed obesity and cardiometabolic care.

To access the full Milliman report or learn more, visit www.flytehealth.com.

The post AI-Powered Obesity Care: FlyteHealth Delivers Big Wins for Connecticut’s Public Employees appeared first on Medika Life.

Q&A

Gil Bashe: You called Converge\OIST the “very first gathering.” Why did Okinawa feel like the right birthplace?

Yasushi Yamamoto: Yes, this is the very first gathering, and we named it Converge\OIST because I’m a big fan of ‘OIST’—the context of the birth, this location, these people. It was the right place and people, a great gathering, and a pleasure to meet old friends in such a beautiful, inspiring place.

Gil Bashe: Your career bridges Tokyo boardrooms and Jerusalem start-ups. Where did your obsession with “convergence” begin?

Yasushi Yamamoto: Innovation cannot be done in an isolated form; it should be done in collaboration with various fields. Professionals with beautiful résumés in Tokyo surround me, but many lack a broader vision. They are so good at something particular, yet it’s a pity they’re busy in silos. I saw the lack of collaboration and started my business, raising money from Japanese corporations for Israeli start-ups. That contrast—dinosaurs with big systems but little ‘challenging spirit’ versus entrepreneurs who ‘run and fix’—motivated me to build synergy between powerful pieces.

Gil Bashe: Modern medicine seems to multiply silos every year. How do you see convergence breaking that pattern?

Yasushi Yamamoto: Medicine has become hyper-specialized. We have gastroenterologists who only look at the upper esophagus or the colon, cardiologists in electrophysiology, and neurologists focused on one nerve pathway. They perfect an art, but they have blinders. Convergence is breaking down those walls.

Gil Bashe: Inviting violinists and AI ethicists to the same podium can feel radical. How did people react when you pitched this mix?

Yasushi Yamamoto: People would never believe me if I hadn’t done serious work in the previous decade. Thanks to that track record, we built trust. Gathering in Okinawa sounded out of context for many professionals, but it wasn’t curiosity but trust that made them come.

Gil Bashe: Every July, you disappear into Kyoto’s 1,200-year-old Gion festival to play the traditional Japanese flute. What does a month of music teach a CEO?

Yasushi Yamamoto: Back home, I’m participating and serving. When I set up my company, I realized it would never be greater than this festival. The experience makes me humble. I received a baton from previous generations and must pass it on to the next. After that month, I ask, ‘Two generations later, how will young people judge the work I’m doing now?’

Gil Bashe: You’ve spoken of building on three “wheels”: science, art, and philosophy. Where is Corundum on that journey?

Yasushi Yamamoto: We started in hardcore science and investment, then gradually expanded to art—like Leonardo da Vinci, artist and scientist in one person. In the coming three to five years, I will put the vehicle of philosophy on top. Combining great minds and spirit, we can create something AI alone cannot deliver.

Gil Bashe: What tangible outcomes do you want from Converge?

Yasushi Yamamoto: First, I want to support OIST, an institution I love. We held the first event there; followed by South by Southwest London. I want more gatherings in multiple locations, bringing talented people with good hearts.

Gil Bashe: You’ve set up subsidiaries for neuroscience, virtual mixed human-data AI, and the microbiome. Why those intersections?

Yasushi Yamamoto: Think of the gut–brain axis. Discovery comes from interaction: AI power, system biology, and the microbiome. Add the element of art to inspire other curious, intelligent people, and the community expands.

Gil Bashe: Food as medicine used to be folk wisdom; you’re turning it into data science. How?

Yasushi Yamamoto: We invested in a project from the Weizmann Institute—the deepest phenotype cohort, hundreds of people over 20 years with genes, metabolites, behavior, nutrition. We link ancient wisdom to ultra-modern science by layering AI on that dataset. We are converging the past, the future, and current ways of life.

Gil Bashe: Philosophy sounds noble, but ventures need cash. How do you square capital with conscience?

Yasushi Yamamoto: I strongly believe in setting vision on a solid philosophical idea, but also in the power of capital. Our job is to propose a hypothesis, bring capital, deploy people, and prove the hypothesis with action. So, we’re raising our next venture fund while creating the Corundum Convergence Institute, a U.S. 501(c)(3), as an alternative financing model to advance science.

CLOSING THOUGHTS

Yamamoto-san reframes the entrepreneur’s impossible triangle—mission, money, and meaning—into an orchestral score. Science provides the bass line, art supplies melody, philosophy sets tempo, and well-deployed capital funds the concert hall. As Converge expands from Okinawa to London and beyond, its founder is betting that harmony, not hierarchy, will unlock the next era of precision health.

The takeaway is disarmingly simple for the rest of us: when great minds tune their instruments to work in harmony, the walls separating our disciplines start to fall—and patients everywhere will hear the music of life-sustaining innovation.

According to Gil Granot Mayer, Executive Vice President, Technology Development & Innovation at OIST:

“In just two days, we managed to connect people from different disciplines and geographies, immersing them in the OIST spirit and Okinawa’s culture. From understanding the value of the long tail to different approaches to improving life through the Human Phenotype Project, or the understanding of a new aging mechanism associated with cell membrane damage. I hope that these new connections and cutting-edge talks will spark new collaborations and great results.”

The post Blending Renaissance Thinking and Collaborative Power to Address Global Health Challenges appeared first on Medika Life.

After cardiac surgery, patients are at risk for both high and low blood sugar, which can lead to serious complications. Managing these fluctuations requires careful insulin dosing, but existing protocols often fall short due to the unpredictable nature of ICU care and differences among patients, say the investigators. 

To address this challenge, the research team created a reinforcement learning model, named GLUCOSE, that recommends insulin doses tailored to each patient’s needs. In tests using data from real-world ICU cases, GLUCOSE matched or even outperformed experienced clinicians in keeping blood sugar levels within a safe range—despite having access to only current patient data, while doctors used full patient histories. 

“Our study shows that artificial intelligence can be thoughtfully and responsibly developed to support, rather than replace, the clinical judgment of health care professionals,” says co-senior corresponding author Ankit Sakhuja, MBBS, MS, Associate Professor of Medicine (Data-Driven and Digital Medicine) and a member of the Institute for Critical Care Medicine at the Icahn School of Medicine at Mount Sinai. “In complex and high-pressure environments like the ICU, tools like GLUCOSE can provide real-time data-driven guidance tailored to individual patients. This kind of decision support can enhance safety, reduce the risk of complications, and ultimately allow clinicians to focus more of their attention on critical aspects of patient care.” 

The research team trained GLUCOSE using reinforcement learning, which allowed the system to learn optimal decisions through trial and error. They also used advanced methods—conservative and distributional reinforcement learning—to ensure the model made cautious, reliable recommendations. The model was then rigorously evaluated and compared to real-world clinical practices. 

While the results are promising, the researchers caution that GLUCOSE is not intended to replace doctors. It serves as a clinical decision support tool, offering suggestions that physicians can choose to follow based on their judgment and the broader clinical picture. 

The model could eventually be integrated into electronic health record systems to provide real-time insulin dosing guidance in the ICU, helping reduce complications and improve outcomes. Future steps include adapting the tool for use in other hospital settings, running clinical trials, and exploring ways to integrate it into routine care. 

One current limitation is that the model does not yet factor in nutrition data, which may affect longer-term glucose control. Still, the ability of GLUCOSE to make accurate recommendations based on limited real-time data highlights its potential to enhance safety and efficiency in postsurgical care. 

“Our goal is to develop AI systems that meaningfully augment the capabilities of health care providers and ultimately improve patient outcomes,” says co-senior corresponding author Girish N. Nadkarni, MD, MPH, Chair of the Windreich Department of Artificial Intelligence and Human Health, Director of the Hasso Plattner Institute for Digital Health, and Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and Chief AI Officer of the Mount Sinai Health System. “By learning from real-world clinical data and delivering personalized recommendations in real time, models like GLUCOSE represent an important advance toward integrating trustworthy data-driven tools into the clinical workflow. This study offers a glimpse of how AI can be thoughtfully embedded into care to support providers in delivering safer, more precise treatment.” 

The paper is titled “A Distributional Reinforcement Learning Model for Optimal Glucose Control After Cardiac Surgery.” 

The study’s authors, as listed in the journal, are Jacob M. Desman, Zhang-Wei Hong, Moein Sabounchi, Ashwin S. Sawant, Jaskirat Gill, Ana C. Costa, Gagan Kumar, Rajeev Sharma, Arpeta Gupta, Paul McCarthy, Veena Nandwani, Doug Powell, Alexandra Carideo, Donnie Goodwin, Sanam Ahmed, Umesh Gidwani, Matthew A. Levin, Robin Varghese, Farzan Filsoufi, Robert Freeman, Avniel Shetreat-Klein, Alexander W. Charney, Ira Hofer, Lili Chan, David Reich, Patricia Kovatch, Roopa Kohli-Seth, Monica Kraft, Pulkit Agrawal, John A. Kellum, Girish N. Nadkarni, and Ankit Sakhuja. 

The study was funded, in part, by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health grant 5K08DK131286, and by the Clinical and Translational Science Awards (CTSA) grant UL1TR004419 from the National Center for Advancing Translational Sciences. Research reported in this publication was also supported by the Office of Research Infrastructure of the National Institutes of Health under award numbers S10OD026880 and S10OD030463.  

See the journal paper for conflicts of interest: https://www.nature.com/articles/s41746-025-01709-9. 

About Mount Sinai’s Windreich Department of AI and Human Health   

Led by Girish N. Nadkarni, MD, MPH—an international authority on the safe, effective, and ethical use of AI in health care—Mount Sinai’s Windreich Department of AI and Human Health is the first of its kind at a U.S. medical school, pioneering transformative advancements at the intersection of artificial intelligence and human health.  

The Department is committed to leveraging AI in a responsible, effective, ethical, and safe manner to transform research, clinical care, education, and operations. By bringing together world-class AI expertise, cutting-edge infrastructure, and unparalleled computational power, the department is advancing breakthroughs in multi-scale, multimodal data integration while streamlining pathways for rapid testing and translation into practice.  

The Department benefits from dynamic collaborations across Mount Sinai, including with the Hasso Plattner Institute for Digital Health at Mount Sinai—a partnership between the Hasso Plattner Institute for Digital Engineering in Potsdam, Germany, and the Mount Sinai Health System—which complements its mission by advancing data-driven approaches to improve patient care and health outcomes.  

At the heart of this innovation is the renowned Icahn School of Medicine at Mount Sinai, which serves as a central hub for learning and collaboration. This unique integration enables dynamic partnerships across institutes, academic departments, hospitals, and outpatient centers, driving progress in disease prevention, improving treatments for complex illnesses, and elevating quality of life on a global scale.  

In 2024, the Department’s innovative NutriScan AI application, developed by the Mount Sinai Health System Clinical Data Science team in partnership with Department faculty, earned Mount Sinai Health System the prestigious Hearst Health Prize. NutriScan is designed to facilitate faster identification and treatment of malnutrition in hospitalized patients. This machine learning tool improves malnutrition diagnosis rates and resource utilization, demonstrating the impactful application of AI in health care.  

For more information on Mount Sinai’s Windreich Department of AI and Human Health, visit: ai.mssm.edu  

The post AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery appeared first on Medika Life.

The lead content of surface enamel at that time was determined to be high. A number of widely used dentifrices were tested for lead since it was suspected that they could be a source of this element. Every single sample tested positive for lead.

Toothpaste samples taken from certain brands showed high levels of lead in the areas immediately surrounding the product container’s walls. When squeezed from nearly empty tubes, the paste contained substantial levels of lead in these tests. These findings left little doubt that these products contained a neurotoxin that could cause harm if ingested. How many years ago was that? Yes, that was 45 years ago, and we have continued to use products that may not be as safe as they should be. But what’s the specific problem, and shouldn’t we have been protected by the agencies given that charge?

Children and Lead Exposure

There are several well-documented negative impacts of lead exposure on children’s health, including:

Brain and neurological system injury
Decreased development
Issues with learning and conduct disorders
Speech and hearing impairments

Resulting in:

Reduced intelligence of a lifelong nature
Minimal capacity for sustained attention
Academic underachievement

In children, we need to be especially concerned, as this is where the most damage can occur, and the consequences can be lifelong. Lead is harmful to children because it enters the bloodstream rapidly. Once in the bloodstream, lead is transported to the brain, bones, and every part of a child’s body. It is insidious and may not be detected immediately except when specific blood tests are performed. The question here, of course, is whether or not lead is suspected to be the culprit, and testing is ordered.

A child’s blood lead level will increase if they ingest lead. However, blood lead levels decline over time when a child’s exposure to lead ends. However, despite decreasing levels of lead, not all lead will be eliminated, and this is where the damage lies.

Kidney, perspiration, and feces are excreted by the body as a portion of the lead. Bones are another repository for lead. Lead levels in bones can decline over decades. But there’s more here than we would suspect, and we would be lulled into a false sense of security that the body has a natural ability to read itself of lead. The story is more complex than that.

Due to its ability to penetrate and remain in the body, lead is extremely harmful to children’s health. Lead can enter the blood circulation and even reach the brain when a kid breathes lead dust or consumes lead particles. Remember the toothpaste that we mentioned earlier? Lead, alarmingly, can lodge in bones and soft tissues, where it can stay for decades, unlike many poisons that the body removes.

One reason lead is so harmful is that it resembles calcium and iron, two essential minerals necessary for a growing body. Lead, when ingested, mimics these essential nutrients and fools cells into utilizing them instead. This change disrupts the brain’s normal development and functioning.

Like insulation, the protective myelin layer around nerve cells is likewise damaged by lead. Damage to this coating prevents the normal transmission of nerve signals throughout the brain. Physical and mental development, as well as learning and processing information, are all impacted by this harm. It is crucial to limit lead exposure in youngsters because the consequences can be long-lasting and happen at very low exposure levels.

Toothpaste Current Research

After all these years, researchers decided to revisit the exploration of currently available toothpastes and other potential sources of metal contamination. The results are anything but heartening and have raised new concerns for even the most well-known brands of toothpaste.

Many of the popular brands were included in a 2025 research project, and a chart is available here. In fact, you can find information on multiple products and their safety regarding contamination by lead or other materials here. It’s not only toothpaste that we need to be concerned about because we’ve recently been made aware of contaminants, such as metals, in baby food.

In the area of toothpaste, especially for children, 51 Brands were tested and, unfortunately, even those that were supposed to be “green” had issues with contamination. Lead was present in approximately 90% of toothpastes, arsenic in 65%, mercury in slightly less than half, and cadmium in one-third. Many brands have some harmful substances. Many popular brands were found to contain harmful substances, including Crest, Sensodyne, Tom’s of Maine, Dr. Bronner’s, and others.

In their defense, several corporations have pointed out that lead is ubiquitous in nature and thus impossible to eliminate. Currently, the federal Baby Food Safety Act of 2024 is stuck in Congress, which would limit lead levels in children’s food to 10 parts per billion. The lead limit in infant food in California is six parts per billion; however, this does not apply to toothpaste. The majority of toothpastes surpassed those levels.

You can find arsenic in nature just about everywhere: rocks, dirt, water, air, and even some living things. Organic chemicals, including those found in seafood (such as fish and shellfish), are one possible form they can take. However, when we detect unacceptable levels of any heavy metal, such as lead, in a product intended for oral use or ingestion, it is mandatory that we take every possible step to eliminate it. To do less is unconscionable and damaging to children and adults.

As always, it is wise to inform yourself about all the foods and materials that you will either ingest or apply to your body. This research would not have seemed necessary, except that almost 50 years ago, lead was found in toothpaste. Now that we have the information, we can act intelligently with it and protect ourselves and our children.

The post STOP! Brushing Your Teeth May Expose You to Deadly Neurotoxins appeared first on Medika Life.